WallStSmart

Co-Diagnostics, Inc. Common Stock (CODX)vsMedtronic PLC (MDT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Medtronic PLC generates 5700233% more annual revenue ($35.48B vs $622,490). MDT leads profitability with a 13.0% profit margin vs 0.0%. MDT earns a higher WallStSmart Score of 58/100 (C).

CODX

Hold

41

out of 100

Grade: D

Growth: 7.3Profit: 2.5Value: 5.0Quality: 5.0

MDT

Buy

58

out of 100

Grade: C

Growth: 4.0Profit: 6.5Value: 6.7Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for CODX.

MDTUndervalued (+25.1%)

Margin of Safety

+25.1%

Fair Value

$108.03

Current Price

$79.37

$28.66 discount

UndervaluedFair: $108.03Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CODX3 strengths · Avg: 9.3/10
Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
76.7%10/10

Revenue surging 76.7% year-over-year

EPS GrowthGrowth
30.8%8/10

Earnings expanding 30.8% YoY

MDT4 strengths · Avg: 8.3/10
Market CapQuality
$103.96B9/10

Large-cap with strong market position

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

Operating MarginProfitability
20.0%8/10

Strong operational efficiency at 20.0%

Free Cash FlowQuality
$2.30B8/10

Generating 2.3B in free cash flow

Areas to Watch

CODX4 concerns · Avg: 2.5/10
Market CapQuality
$5.94M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-125.9%2/10

ROE of -125.9% — below average capital efficiency

Free Cash FlowQuality
$-6.33M2/10

Negative free cash flow — burning cash

MDT1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-11.8%2/10

Earnings declined 11.8%

Comparative Analysis Report

WallStSmart Research

Bull Case : CODX

The strongest argument for CODX centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 76.7% demonstrates continued momentum.

Bull Case : MDT

The strongest argument for MDT centers on Market Cap, Price/Book, Operating Margin. PEG of 1.38 suggests the stock is reasonably priced for its growth.

Bear Case : CODX

The primary concerns for CODX are Market Cap, Profit Margin, Return on Equity.

Bear Case : MDT

The primary concerns for MDT are EPS Growth.

Key Dynamics to Monitor

CODX profiles as a hypergrowth stock while MDT is a value play — different risk/reward profiles.

CODX carries more volatility with a beta of 1.43 — expect wider price swings.

CODX is growing revenue faster at 76.7% — sustainability is the question.

MDT generates stronger free cash flow (2.3B), providing more financial flexibility.

Bottom Line

MDT scores higher overall (58/100 vs 41/100). Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Co-Diagnostics, Inc. Common Stock

HEALTHCARE · MEDICAL DEVICES · USA

Co-Diagnostics, Inc., a molecular diagnostic company, develops, manufactures, and sells reagents used for diagnostic tests that function by detecting and / or analyzing nucleic acid molecules. The company is headquartered in Salt Lake City, Utah.

Medtronic PLC

HEALTHCARE · MEDICAL DEVICES · USA

Medtronic plc is an American-Irish registered medical device company that primarily operates in the United States. Medtronic has an operational and executive headquarters in Fridley, Minnesota in the US.

Want to dig deeper into these stocks?